7
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Coumarins as Antimitotics

, , , , , & show all
Pages 262-273 | Accepted 08 Mar 1993, Published online: 27 Sep 2008
 

Abstract

Coumarin, Two Of Its Hydroxy Derivatives (Umbelliferone and 4-Hydroxycoumarin), and Two Furano-Coumarins (Psoralen and Xanthotoxin) Were Investigated For Their Potential Use As Mitodepressants. In Sublethal Concentrations These Compounds Stopped Mitosis (Umbelliferone Inhibited 95%) In 24 H Incubations. All Phases Of Mitosis Were Affected In The Same Proportions, Except Umbelliferone, Which Prolonged Prophase and Blocked Metaphase. In Postincubation, The Meristematic Cells Kept In Coumarin Solution Did Not Recover. Postincubation Of Umbelliferone and 4-Hydroxycoumarin Resulted In Mitoses Reaching 40% and 120% Of The Control, Respectively. Furanocoumarins Showed A Few Mitoses In 24 H Postincubation, But After 72 H No Mitoses Occurred. Chromosomal Aberrations Were Not Observed After Coumarin and 4-Hydroxycoumarin Treatment. Umbelliferone Caused Shortening and Thickening Of Chromosomes, Caused Postponement Of Chromatid Separation, Occurrence Of Sticky Ends Leading To Anaphase, and Telophase Bridges. Similar Types Of Aberration, But More Frequent, Were Observed For Furanocoumarins, Which Additionally Showed Severe Aberrations Of Fragmoplast Formation Leading To The Occurrence Of Binucleate Cells, Micronuclei, Some Tetraploid Nuclei With Irregular Surfaces, and Fragmoplasts Located In Distant Areas Of The Cell.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.